On May 9, 2024, the U.S. Department of Justice’s Antitrust Division (“DOJ”) announced a new task force to address “pressing antitrust problems in health care markets.” This new initiative, named the Task Force on Health Care Monopolies and Collusion (“HCMC”), will focus on DOJ’s view that there are “widespread competition concerns shared by patients, health care professionals, businesses and entrepreneurs, including issues regarding payer-provider consolidation, serial acquisitions, labor and quality of care, medical billing, health care IT ...
Blog Editors
Recent Updates
- State AGs in Action: Health Care Enforcement in 2026 – Speaking of Litigation Video Podcast
- The DOJ’s New Corporate Enforcement Policy: A Familiar but Now Nationally Unified Framework for Voluntary Self-Disclosure
- The Case Was Settled, but ChatGPT Thought Otherwise: A Dispute Poised to Define AI Legal Liability
- “Claude Is Not an Attorney”: Individuals Risk Abandoning the Attorney-Client Privilege and Attorney Work-Product Doctrine When Consulting AI
- Prediction Markets v. State Gaming Laws: The Kalshi Litigation Gamble